MARY JAHRAUS: Open Payments
NPI 1689611212 · PIERRE, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 37 payments from 11 companies in 2025. Trend: 2023 $519 · 2024 $521 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $178 |
| Amgen Inc. | 6 | $96 |
| Novo Nordisk Inc | 4 | $66 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Astellas Pharma US Inc | 4 | $61 |
| Procept Biorobotics Corporation | 1 | $29 |
| ABBVIE INC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, EVENITY, JOURNAVX, Veozah, Ozempic, ELIQUIS, AQUABEAM ROBOTIC SYSTEM, UBRELVY.
Industry payments across SD — which companies pay providers there.
